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CONCISE COMMUNICATION
The IFNL3/4 DG variant increases susceptibility to
cytomegalovirus retinitis among HIV-infected patients
Ste´phanie Biberta, Agnieszka Wojtowicza, Patrick Taffe´b,
Oriol Manuela, Enos Bernasconic, Hansjakob Furrerd,
Huldrych F. Gu¨ntharde, Matthias Hoffmannf, Laurent Kaiserg,
Michael Osthoffh, Matthias Cavassinia,M, Pierre-Yves Bochuda,M,
the Swiss HIV Cohort Studyy
Background: Cytomegalovirus (CMV) retinitis is a major cause of visual impairment
and blindness among patients with uncontrolled HIV infections. Whereas polymor-
phisms in interferon-lambda 3 (IFNL3, previously named IL28B) strongly influence the
clinical course of hepatitis C, few studies examined the role of such polymorphisms in
infections due to viruses other than hepatitis C virus.
Objectives: To analyze the association of newly identified IFNL3/4 variant
rs368234815with susceptibility to CMV-associated retinitis in a cohort of HIV-infected
patients.
Design and methods: This retrospective longitudinal study included 4884 white
patients from the Swiss HIV Cohort Study, among whom 1134 were at risk to develop
CMV retinitis (CD4þ nadir <100 /ml and positive CMV serology). The association of
CMV-associated retinitis with rs368234815 was assessed by cumulative incidence
curves and multivariate Cox regression models, using the estimated date of HIV
infection as a starting point, with censoring at death and/or lost follow-up.
Results: A total of 40 individuals among 1134 patients at risk developed CMV retinitis.
The minor allele of rs368234815was associated with a higher risk of CMV retinitis (log-
rank test P¼0.007, recessive mode of inheritance). The association was still significant
in a multivariate Cox regression model (hazard ratio 2.31, 95% confidence interval
1.09–4.92, P¼0.03), after adjustment for CD4þ nadir and slope, HAART and HIV-risk
groups.
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Conclusion: We reported for the first time an association between an IFNL3/4 polymor-
phism and susceptibility to AIDS-related CMV retinitis. IFNL3/4may influence immunity
against viruses other than HCV.  2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
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Introduction
Cytomegalovirus (CMV) retinitis is a major cause of visual
impairment and blindness among patients with uncon-
trolled HIV infections, insufficient drug compliance or
therapy intolerance [1]. The disease is characterized by
progressive necrosis that can lead to retinal detachment,
optic atrophy and finally loss of vision [2–4].
Although individuals can remain asymptomatic for
extended periods of time with low CD4þ cell counts,
others rapidly develop retinitis when their CD4þ cell
count drops below 50–100 CD4þ cells/ml. Such
differences in the onset and/or susceptibility of the
disease may be partly due to host genetic factors. Among
African Americans, a promoter haplotype within C-C
chemokine receptor type 5 (CCR5) and a polymorphism
in the stromal cell-derived factor 1 (SDF1) were
associated with increased risk of retinitis progression
[5,6]. In white patients, different haplotypes of the
interleukin (IL)-10 receptor subunit 1 (IL10-R1) [5] and
polymorphisms within tumor necrosis factor (TNF) [7]
were linked to susceptibility to CMV retinitis.
Interferon-lambda 3 (IFNL3) (previously designated as
IL28B) belongs to the type III IFN family and was
reported as a major determinant of hepatitis C virus
(HCV) clearance. A TT/-G substitution (rs368234815)
introducing a frameshift in the DNA sequence was shown
to be the best marker of HCV clearance [8,9]. The minor
-G allele was recently associated with the expression of a
novel IFN-like protein called IFNL4 [8]. We showed that
this allele was also associated with reduced IFNL3
expression [8,9]. So far, only a few studies examined
whether IFNL3/4 polymorphisms influence immune
responses against viruses other than HCV [10–12]. We
examined the role of this polymorphism in the
development of CMV retinitis among patients from
the Swiss HIV Cohort Study (SHCS).
Material and methods
Study patients
Patients were included from the Swiss HIVCohort Study,
an ongoing multicenter prospective study of HIV-
infected patients enrolled at seven major Swiss hospitals
and their local affiliated centers since 1988.White patients
with available samples for DNA extraction, written con-
sent for genetic studies and a CD4þ nadir below 400/ml
were selected. Demographic characteristics including age,
duration of HIV infection, sex, CD4þ T-cell count nadir,
otheropportunistic infections,HIVmaximal viral load and
HAART use were extracted from clinical databases.
Patients at risk to develop CMV retinitis were defined
as those with a positive CMV serology and a CD4þ T-cell
nadir below 100/ml. CMV retinitis was defined by
characteristic ophthalmoscopic findings (discrete patches
of retinal whitening with distinct borders speeding in a
centrifugal manner, frequently associated with retinal
vasculitis, hemorrhage and necrosis) followed by evidence
of response toCMVtreatment (residual retinal scarring and
atrophy with retinal pigment epithelial mottling). The
disease was considered presumptive unless proven by a
positive CMV PCR detection.
Single-nucleotide polymorphism genotyping
Genomic DNAs isolated either from blood or cell pellets
were genotyped using a customized Golden Gate Geno-
typing Assay on Veracode platform (Illumina, San Diego,
California, USA) or a Competitive Allele Specific PCR
(KASP) system (LGC Genomics, former KBioscience,
Hoddesdon, Herts, UK; http://www.lgcgenomics.com/
kaspchallenge).
Statistical analysis
Statistical analyses were performed using Stata (version
13.1; StataCorp LP, College Station, Texas, USA).
Hardy–Weinberg equilibrium test was assessed using
the program genhw, implemented in Stata. The
association of IFNL3/4 polymorphism with CMV
retinitis for the additive, dominant and recessive modes
of inheritance was assessed by cumulative incidence
curves (i.e. 1 minus Kaplan–Meier to estimate the
cumulative probability of retinitis), using the estimated
date of HIV infection as a starting point, with censoring
at death and/or lost follow-up. Proportional hazard
assumption was verified by using the stphtest command
implemented in Stata. Estimated dates of HIV infection
and CD4þ slopes (rate of CD4þ depletion in the absence
of HAART) in both incident and prevalent cases were
obtained by using a joint back calculation model, as
described previously [13]. The CD4þ nadir square root
was used to obtain a normally distributed variable. The
association between CMV retinitis and genetic variables
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was first assessed using the log-rank test. Demographic
and clinical factors that were potentially associated with
CMV retinitis were then analyzed in univariate and
multivariate Cox regression models. Stepwise (i.e.
backward) regression (P< 0.2) was used to determine
which variables were independently associated with
the endpoint.
Results
The study included 4884 white patients with consent for
host genetic studies from the SHCS, among whom 1134
were at risk of developing CMV retinitis (CD4þ nadir
<100 /ml and positive CMV serology; Supplementary
Table 1, http://links.lww.com/QAD/A544). In this
high-risk group, most patients were male (78%) and
the most frequent risk factors for HIV infection included
homosexual contact (43%), heterosexual contact (32%)
and drug use (21%). The median age at estimated time of
HIV infection was 31 years [interquartile range (IQR)
14]. The median CD4þ T-cell count nadir and CD4þ
slopes were 39.5/ml (IQR 47) and 2.66 (IQR 0.97),
respectively. CMV retinitis was diagnosed in 40/1134
individuals (29 proven and 11 presumptive).
Patients who carried two copies of the minor -G allele of
IFNL3/4 rs368234815 polymorphisms had a signifi-
cantly higher cumulative incidence of CMV retinitis (log-
rank test P¼ 0.007; Fig. 1). The association was still
significant in a multivariate Cox regression model [hazard
ratio 2.31, 95% confidence interval (CI) 1.09–4.92,
P¼ 0.03]. Covariates that remained in the model after
stepwise (backward) selection were the CD4þ cell count
nadir square root (hazard ratio 0.73, 95% CI 0.64–0.84,
P< 0.001), the CD4þ slope (hazard ratio 0.73, 95% CI
0.49–1.07, P¼ 0.11), the use of HAART (hazard ratio
0.40, 95% CI 0.18–0.88, P¼ 0.02), as well as the HIV
transmission mode (heterosexual contact, hazard ratio
0.51, 95%CI 0.23–1.09, P¼ 0.08; intravenous (i.v.) drug
use, hazard ratio 0.35, 95% CI 0.13–0.93, P¼ 0.04, using
MSM as reference; Table 1 and Supplementary Table 2,
http://links.lww.com/QAD/A544).
Discussion
Polymorphisms in IFNL3/4 have a dramatic influence on
HCV clearance, either spontaneously or in response to
IFN-base therapy [8,9]. Few studies examined whether
these polymorphisms influence susceptibility to other
viral pathogens. In this study, we report an associa-
tion between the newly identified IFNL3/4 mutant
rs368234815 allele and susceptibility to CMV retinitis
among HIV-infected patients.
The association between the rs368234815 polymorphism
and susceptibility to CMV retinitis is consistent with
studies performed in the field of hepatitis C, as the same
allele was associated with reduced HCV clearance, either
spontaneously or after IFN-based treatment. In addition,
we recently showed that this polymorphism is associated
with increased CMV infection in a cohort of 1021 solid
organ transplant recipients [14]. This suggests that IFNLs
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Fig. 1. Cumulative incidence curves (i.e. 1 minus Kaplan–Meier-estimated probability) of cytomegalovirus retinitis according to
IFNL3/4 rs368234815 polymorphism. The estimated date of HIV infection was used as a starting point, with censoring at death
or lost follow-up.
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may be involved in the immune response to an extended
range of viral pathogens.
Whereas the functional relevance of this association
remains to be elucidated, increasing evidences suggest
a role for IFNLs in the immune response against
herpesviruses, including CMV. Immune cells can detect
CMV by using two main families of pattern recognition
receptors – the toll-like receptors (TLR2, TLR3, TLR7,
TLR8, TLR9) and the RIG-like receptors (Melanoma
Differentiation-Associated protein 5 (MDA5) and reti-
noic acid-inducible gene 1 (RIG-I)), which lead to the
production of IFNs. IFNs promote the induction of IFN-
stimulated genes (ISGs) which were shown to exert
antiviral activities against a broad range of viruses. For
instance, colonic cells from mice infected with murine
CMV were shown to produce increased amounts
of IFNLs [15]. In turn, IFNLs up-regulated STAT1
phosphorylation and ISG production in different human
intestinal epithelial cells which results in an increased IFN
response due to the expression of ISGs [15]. Recent
studies using different models of CMV retinitis high-
lighted the role of IFNs in the development of Th1
immune responses [16,17] and the contribution of IFNL3
in the regulation of T-cell function and natural killer
(NK)-cell cytotoxicity [18].
The rs368234815 polymorphism was shown to influence
both IFNL3 and IFN-g-inducible protein 10 (IP-10)
mRNA expression in peripheral blood mononuclear cells
(PBMCs) stimulated with Poly(I:C) and to promote the
expression of IFNL4 [8,9]. Thus, increased susceptibility
to retinitis in individuals carrying the polymorphismsmay
result from insufficient IFNL3 and/or the production of
IFNL4. Yet, the mechanisms by which IFNL4 (a cytokine
predicted to exert antiviral activities) can be associated
with increased susceptibility to viral infections has still not
been elucidated [19].
Like most genetic association studies, our study has several
limitations. Whereas the diagnosis of CMV retinitis is
based on stringent clinical and laboratory criteria, the
diagnosis of CMV disease is ill-defined, and its association
with IFNL3/4 polymorphisms was not analyzed in this
study. Whereas most cases of CMV retinitis were
diagnosed as proven (PCR-documented), a few cases
were classified as presumptive (based on a positive CMV
serology and a typical clinical presentation diagnosed
by an ophthalmologist). Finally, the number of CMV
retinitis patients carrying the risk genotype was relatively
small. Further studies are needed to replicate the
association reported in this study, and additional work
is needed to understand the biological role of IFLNs in
CMV retinitis.
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Table 1. Independent risk factors associated with cytomegalovirus retinitis.
Variable
Univariate Multivariate
HR (95% CI)a P HR (95% CI)b P
Sex 0.72 (0.32–1.64) 0.44
Age at estimated date of infection (continuous) 1.00 (0.97–1.03) 0.99
CD4þ nadir (sqrt transformed, continuous) 0.71 (0.63–0.81) <0.001 0.73 (0.64–0.84) <0.001
CD4þ slope (continuous) 0.64 (0.45–0.92) 0.01 0.73 (0.49–1.07) 0.11
Maximal HIV RNA load (continuous) 1.38 (0.87–2.17) 0.17
HAART (time-dependent covariate)a 0.48 (0.24–0.97) 0.04 0.40 (0.18–0.88) 0.02
Risk factors
MSM Ref.
Hetero 0.57 (0.27–1.20) 0.14 0.51 (0.23–1.09) 0.08
Drug user 0.40 (0.15–1.06) 0.06 0.35 (0.13–0.93) 0.04
Other 0.53 (0.07–3.93) 0.54
HCV coinfection 1.03 (0.55–1.93) 0.92
Active HBV infection 0.88 (0.21–3.63) 0.86
IFNL3 rs368234815 (-G/-G versus TT/TT or TT/-G) 2.59 (1.26–5.29) 0.009 2.31 (1.09–4.92) 0.03
Stepwise (i.e. backward) regression (P<0.2) was used to determine which variables were independently associated with the endpoint. CI,
confidence interval; HBV, hepatitis B virus; HCV, hepatitis C virus; HR, hazard ratio.
aThe proportional hazard assumption was verified for all variables with the exception of HAART (P¼0.03 in the univariate model, P¼0.04 in the
multivariate model). However, the association between IFNL3 rs368234815 and CMV retinitis was similar when HAART was removed from the
multivariate model (HR 2.53, 95% CI 1.20–5.35, P¼0.015) (see supplementary Table 2, http://links.lww.com/QAD/A544).
bThe association between rs368234815 and CMV retinitis was still significant when anti-CMV treatment was added into the model (HR 2.55, 95%
CI 1.20–5.43, P¼0.015).
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